Trade JnJ ^JNJ

Bank of America Cuts Johnson & Johnson (NYSE:JNJ) Price Target to $159.00

Johnson & Johnson (NYSE:JNJ) Q4 2024 Earnings Call Transcript

Abacus Wealth Partners LLC Lowers Stake in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Bought by Hoese & Co LLP

Hoese & Co LLP Has $362,000 Stake in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Acquired by ZWJ Investment Counsel Inc.

Zhang Financial LLC Has $1.79 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Sold by Harbor Investment Advisory LLC

Overbrook Management Corp Reduces Stock Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Sold by LaFleur & Godfrey LLC

Guinness Asset Management LTD Has $201.43 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Sold by MassMutual Private Wealth & Trust FSB

Johnson & Johnson (JNJ) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus

Johnson & Johnson (NYSE:JNJ) Shares Gap Down After Analyst Downgrade

Zacks Earnings Trends Highlights: Netflix and Johnson & Johnson - January 23, 2025 - Zacks.com

Plaintiff Argues Jury's $22M Punitive Damages Finding Undermines J&J's Talc Trial Win

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance | Morningstar

Johnson & Johnson (NYSE:JNJ) Shares Down 3.1% on Analyst Downgrade

Johnson & Johnson (NYSE:JNJ) Shares Gap Down Following Analyst Downgrade

Johnson & Johnson (JNJ) Stock Falls Over 3.8% Despite Beating Q4 Estimates

J&J reports Q4 sales, profit above estimates on cancer drug sales | Company Results - Business Standard

J&J CFO Joe Wolk: Anticipating 3% operational growth in 2025 despite 'significant' headwinds

Johnson & Johnson (NYSE:JNJ) Announces Earnings Results

J&J Tops Quarterly Profit Estimates on Cancer Drug Sales

Johnson & Johnson Projects 2025 Adj. Operational EPS Growth Of 8.7% At Midpoint, Excl. ITCI

Johnson & Johnson (JNJ) Q4 earnings

J&J's stock surrenders early gains as weak sales guidance offsets earnings beat | Morningstar

J&J's earnings beat estimates but guidance is mixed | Morningstar

J&J tops earnings estimates amid strong demand for cancer treatments By Investing.com

Johnson & Johnson Q4 Earnings: Revenue Hits $22.5 Billion, Adjusted EPS of $2. ...

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024 | The Manila Times

Johnson & Johnson (NYSE:JNJ) Holdings Raised by Pine Haven Investment Counsel Inc

Netflix, Nvidia lead Wednesday's market cap stock movers By Investing.com

Legend Biotech stock target cut to $91 by Jefferies By Investing.com

Johnson & Johnson (NYSE:JNJ) Shares Sold by Bridgewater Advisors Inc.

UMB Bank n.a. Has $46.19 Million Position in Johnson & Johnson (NYSE:JNJ)

M.E. Allison & CO. Inc. Takes $1.01 Million Position in Johnson & Johnson (NYSE:JNJ)

Diversify Wealth Management LLC Boosts Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Holdings Raised by Ellsworth Advisors LLC

6,134 Shares in Johnson & Johnson (NYSE:JNJ) Purchased by Brady Martz Wealth Solutions LLC

J&J's Q4 Earnings Beat, Stock Down on Tepid 2025 Sales Guidance

Johnson & Johnson Earnings: Maintaining Fair Value Estimate Despite Heavy Stelara Hit in 2025 | Morningstar

Earnings call transcript: Johnson & Johnson Q3 2024 beats EPS forecast By Investing.com

Jim Cramer on Johnson & Johnson (JNJ): 'Make Good Money Just By Reinvesting Their Juicy Dividends'

FDA approves standalone use of J&J's ketamine-derived depression treatment | CNN

Earnings Picture Remains Strong: A Closer Look - January 22, 2025 - Zacks.com

J&J's Depression Drug Spravato Gets FDA Nod for Monotherapy Use - January 22, 2025 - Zacks.com

FDA Approves Johnson & Johnson's Spravato for Treatment-Resistant Depression

Johnson & Johnson (NYSE:JNJ) Shares Up 0.7% - What's Next?

Spravato (esketamine) Approved in the U.S. as the First and Only Monotherapy for Adults with Treatment-Resistant Depression

Stock Traders Buy Large Volume of Call Options on Johnson & Johnson (NYSE:JNJ)

Psoriasis Pipeline 2024: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Johnson and Johnson, Janssen Biotech, Leo Pharma, Merck, Novartis, Pfizer, AbbVie Inc

JNJ's SNDA For Spravato Monotherapy Gets FDA Approval For Treatment-Resistant Depression

FDA Approves Ketamine-based Nose Spray for Depression | Newsmax.com

RBC Capital cuts Intra-Cellular stock rating, hikes target to $132 By Investing.com

FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment

depression: J&J's ketamine-based nasal spray Spravato approved by US FDA to treat depression - The Economic Times

FDA approves SPRAVATO as first monotherapy for MDD By Investing.com

Kinder Morgan, P&G, J&J, and more set to report earnings Wednesday By Investing.com

Ballast Inc. Has $3.26 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

MNI US EARNINGS SCHEDULE - Industrials in Focus

Cadinha & Co. LLC Buys 1,825 Shares of Johnson & Johnson (NYSE:JNJ)

Bowman & Co S.C. Has $1.37 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Whitaker Myers Wealth Managers LTD. Makes New Investment in Johnson & Johnson (NYSE:JNJ)

Q4 Earnings: 3 Consumer Staples Titans on Deck

European Commission approves LAZCLUZE®▼ (lazertinib) in combination with RYBREVANT®▼ (amivantamab) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer | Valuespectrum.com

Big Tech, billionaire donors at Trump's inauguration

HEALTHCARE: Johnson & Johnson (JNJ: Aaa/AAA *-): 4Q24 Preview

KRS Capital Management LLC Decreases Holdings in Johnson & Johnson (NYSE:JNJ)

Howard Financial Services LTD. Raises Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Position Boosted by HB Wealth Management LLC

Premier Path Wealth Partners LLC Has $2.33 Million Holdings in Johnson & Johnson (NYSE:JNJ)

CGN Advisors LLC Increases Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Position Boosted by Financial & Tax Architects LLC

Ameritas Advisory Services LLC Decreases Holdings in Johnson & Johnson (NYSE:JNJ)

Verity & Verity LLC Purchases 10,050 Shares of Johnson & Johnson (NYSE:JNJ)

Sanibel Captiva Trust Company Inc. Cuts Stock Position in Johnson & Johnson (NYSE:JNJ)

Atwater Malick LLC Cuts Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Bought by Canoe Financial LP

Spring Capital Management LLC Increases Position in Johnson & Johnson (NYSE:JNJ)

Arkadios Wealth Advisors Decreases Stake in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (JNJ) Projected to Post Quarterly Earnings on Wednesday

Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Earnings? - January 20, 2025 - Zacks.com

Why Intra-Cellular Therapies, Inc. (ITCI) Dominated Last Week's Rally

Somerset Trust Co Has $5.44 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

Butensky & Cohen Financial Security Inc. Has $4 Million Stake in Johnson & Johnson (NYSE:JNJ)

Chemistry Wealth Management LLC Sells 315 Shares of Johnson & Johnson (NYSE:JNJ)

Earnings playbook: Your guide to this week's biggest reports, including Netflix

Brooklyn Investment Group Boosts Position in Johnson & Johnson (NYSE:JNJ)

Tesla Model Y Price Hike Sparks Debate Across Canada

Gold Coin Prices Steady Amid Dollar Weakness

Apple Stock News Amid Revenue Diversification

Morning Note: BOJ’s Rate Hike: How Will It Shape Markets?

Trump Stock Market & Netflix Stock Outlook

Morning Note: How Trump's Energy Plan and Global Market Trends Are Shaping Investments

NFLX stock News today: Netflix stock jumped over 14%

Dow Jones rises ahead of potential interest rate cuts